Skip to content

Immediate Versus Delayed IUD Insertion After Second Trimester Medical Abortion

Immediate Versus Delayed Insertion of the Copper IUD After Second-trimester Medical Abortion - a Randomised Controlled Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03505047
Enrollment
110
Registered
2018-04-23
Start date
2018-05-10
Completion date
2020-01-31
Last updated
2020-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception

Keywords

second trimester medical abortion, Immediate versus delayed insertion, copper intrauterine device

Brief summary

The main objective of the study is to compare use, in a randomised controlled trial, of the the copper IUD if inserted immediately after completion of a second trimester medical abortion, to standard care with insertion 3-4 or more weeks after abortion at community health centres.

Interventions

Immediate insertion of the copper intrauterine device after completion of abortion

Sponsors

University of California, San Francisco
CollaboratorOTHER
University of Cape Town
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Able to speak English, Afrikaans or Xhosa; * Requesting and eligible for abortion according to standard practice at the hospital; * Gestational age 13-20 weeks verified by ultrasound; * Interested and eligible for the copper IUD as a post-abortion contraceptive method; * Willingness to participate in the trial including follow-up; * Able to provide a working phone & telephone number to allow for contact; * Willing and able to provide informed consent * Staying within one hour travel time of GSH

Exclusion criteria

* Active pelvic inflammatory disease, pelvic tuberculosis; severe thrombocytopenia; * Positive N. Gonorrhea or C. Trachomatis that has not been adequately treated * Copper allergy * Hb \<10g/dL * Uterine anomaly preventing placement of the IUD; cervical cancer or carcinoma in-situ, untreated high grade squamous intraepithelial lesions * Hemorrhage; or ruptured uterus * History of ectopic pregnancy * Wilsons' disease

Design outcomes

Primary

MeasureTime frameDescription
Use of the copper IUD6 weeks after second trimester abortionNumber of women using the IUD
Insertion of the IUD6 weeks after second trimester abortionNumber of IUD insertions

Secondary

MeasureTime frameDescription
Spontaneous expulsion of the IUD6 weeks post-abortionNumber of full and partial expulsions
Removal of IUD and associated factorswithin 3 and 6 months post-abortionNumber of removals
Use of the IUD at 3 months post-abortion3 months after second trimester medical abortionNumber of women using the IUD
Women's satisfaction and acceptability of the IUDReported at 3 and 6 months post-abortion5 point scales
Recurrent pregnancyAt 6 months post-abortionNumber of recurrent pregnancies
Abortion-related and IUD-related complicationswithin 3 months post-abortionNumber of complications
Use of the IUD at 6 months post-abortion6 months after second trimester medical abortionNumber of women using the IUD

Countries

South Africa

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026